News
A NEW daily pill to treat ‘debilitating and life-limiting’ endometriosis will be rolled on the NHS after getting the green ...
Navigating the world of birth control can be overwhelming, especially given the sheer variety of options available today.
Clinical trials have shown linzagolix significantly reduces both menstrual pain and non-menstrual pelvic discomfort compared ...
Linzagolix will only be available for patients whose previous medical or surgical treatments have been unsuccessful.
A recent medical trial could help deliver the first daily weight loss pill capable of cutting down obesity as effectively as ...
Some experts say oral versions of popular weight-loss drugs such as Wegovy could offer people more flexibility and ...
Endometriosis is a painful condition that affects one in 10 women in the UK, and can have a big impact on women's lives. The ...
Linzagolix (Yselty) with hormonal add-back therapy will offer a new at-home treatment option for some women in England with ...
3d
IFLScience on MSNSperm-Blocking Male Contraceptive Could Hit The Market "As Soon As 2028" After Promising 2-Year Trial ResultsThe injectable hydrogel, administered within a 30-minute appointment, prevents sperm movement without blocking ejaculation or ...
An implantable, non-hormonal male contraceptive has been shown in trials to last for at least two years. The contraceptive, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results